242 related articles for article (PubMed ID: 21796104)
1. Oxytocin reduces background anxiety in a fear-potentiated startle paradigm: peripheral vs central administration.
Ayers LW; Missig G; Schulkin J; Rosen JB
Neuropsychopharmacology; 2011 Nov; 36(12):2488-97. PubMed ID: 21796104
[TBL] [Abstract][Full Text] [Related]
2. Oxytocin reduces background anxiety in a fear-potentiated startle paradigm.
Missig G; Ayers LW; Schulkin J; Rosen JB
Neuropsychopharmacology; 2010 Dec; 35(13):2607-16. PubMed ID: 20844476
[TBL] [Abstract][Full Text] [Related]
3. Effects of oxytocin on background anxiety in rats with high or low baseline startle.
Ayers L; Agostini A; Schulkin J; Rosen JB
Psychopharmacology (Berl); 2016 Jun; 233(11):2165-2172. PubMed ID: 27004789
[TBL] [Abstract][Full Text] [Related]
4. Oxytocin receptor neurotransmission in the dorsolateral bed nucleus of the stria terminalis facilitates the acquisition of cued fear in the fear-potentiated startle paradigm in rats.
Moaddab M; Dabrowska J
Neuropharmacology; 2017 Jul; 121():130-139. PubMed ID: 28456687
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological analysis of fear-potentiated startle.
Davis M
Braz J Med Biol Res; 1993 Mar; 26(3):235-60. PubMed ID: 8257926
[TBL] [Abstract][Full Text] [Related]
6. Treatment with a heat-killed preparation of Mycobacterium vaccae after fear conditioning enhances fear extinction in the fear-potentiated startle paradigm.
Hassell JE; Fox JH; Arnold MR; Siebler PH; Lieb MW; Schmidt D; Spratt EJ; Smith TM; Nguyen KT; Gates CA; Holmes KS; Schnabel KS; Loupy KM; Erber M; Lowry CA
Brain Behav Immun; 2019 Oct; 81():151-160. PubMed ID: 31175996
[TBL] [Abstract][Full Text] [Related]
7. Food-Restriction Lowers the Acoustic Startle Response in both Male and Female Rats, and, in Combination with Acute Ghrelin Injection, Abolishes the Expression of Fear-Potentiated Startle in Male Rats.
Toufexis DJ; Lipatova O; Johnson AC; Abizaid A
J Neuroendocrinol; 2016 Nov; 28(11):. PubMed ID: 27754564
[TBL] [Abstract][Full Text] [Related]
8. Fear-potentiated startle in rats.
Davis M
Curr Protoc Neurosci; 2001 May; Chapter 8():Unit 8.11A. PubMed ID: 18428539
[TBL] [Abstract][Full Text] [Related]
9. Fear-potentiated startle: a neural and pharmacological analysis.
Davis M; Falls WA; Campeau S; Kim M
Behav Brain Res; 1993 Dec; 58(1-2):175-98. PubMed ID: 8136044
[TBL] [Abstract][Full Text] [Related]
10. Fear-potentiated startle and light-enhanced startle models in drug discovery.
Groenink L; Bijlsma EY; Olivier B
Curr Protoc Pharmacol; 2008 Jun; Chapter 5():Unit5.48. PubMed ID: 22294228
[TBL] [Abstract][Full Text] [Related]
11. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.
Walker DL; Ressler KJ; Lu KT; Davis M
J Neurosci; 2002 Mar; 22(6):2343-51. PubMed ID: 11896173
[TBL] [Abstract][Full Text] [Related]
12. Lasting effect of repeated cocaine administration on acoustic and fear-potentiated startle in rats.
Gordon MK; Rosen JB
Psychopharmacology (Berl); 1999 May; 144(1):1-7. PubMed ID: 10379618
[TBL] [Abstract][Full Text] [Related]
13. Two-week treatment with the selective serotonin reuptake inhibitor citalopram reduces contextual anxiety but not cued fear in healthy volunteers: a fear-potentiated startle study.
Grillon C; Chavis C; Covington MF; Pine DS
Neuropsychopharmacology; 2009 Mar; 34(4):964-71. PubMed ID: 18800069
[TBL] [Abstract][Full Text] [Related]
14. The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle.
Grillon C; Baas JM; Pine DS; Lissek S; Lawley M; Ellis V; Levine J
Biol Psychiatry; 2006 Oct; 60(7):760-6. PubMed ID: 16631127
[TBL] [Abstract][Full Text] [Related]
15. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear.
Walker DL; Davis M
J Neurosci; 1997 Dec; 17(23):9375-83. PubMed ID: 9364083
[TBL] [Abstract][Full Text] [Related]
16. The anxiolytic action of mGlu2/3 receptor agonist, LY354740, in the fear-potentiated startle model in rats is mechanistically distinct from diazepam.
Tizzano JP; Griffey KI; Schoepp DD
Pharmacol Biochem Behav; 2002 Sep; 73(2):367-74. PubMed ID: 12117591
[TBL] [Abstract][Full Text] [Related]
17. Acute hydrocortisone treatment increases anxiety but not fear in healthy volunteers: a fear-potentiated startle study.
Grillon C; Heller R; Hirschhorn E; Kling MA; Pine DS; Schulkin J; Vythilingam M
Biol Psychiatry; 2011 Mar; 69(6):549-55. PubMed ID: 21277566
[TBL] [Abstract][Full Text] [Related]
18. Noradrenergic agonists and antagonists: effects on conditioned fear as measured by the potentiated startle paradigm.
Davis M; Redmond DE; Baraban JM
Psychopharmacology (Berl); 1979 Oct; 65(2):111-8. PubMed ID: 117478
[TBL] [Abstract][Full Text] [Related]
19. No effect of sex and estrous cycle on the fear potentiated startle response in rats.
Zhao Y; Bijlsma EY; Verdouw MP; Groenink L
Behav Brain Res; 2018 Oct; 351():24-33. PubMed ID: 29803653
[TBL] [Abstract][Full Text] [Related]
20. Activation of somatodendritic 5-HT
Zhao Y; Bijlsma EY; Ter Heegde F; Verdouw MP; Garssen J; Newman-Tancredi A; Groenink L
Psychopharmacology (Berl); 2019 Apr; 236(4):1171-1185. PubMed ID: 30539269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
